Retour aux projets

16312.1 PFLS-LS

Development of novel bacterial sortase enzymes for site-specific conjugation of payloads to antibodies

Résumé

Development of novel bacterial sortase enzymes for site-specific conjugation of payloads to antibodies

Textes supplémentaires

Abstract

Antibody conjugates have recently been proven to be highly potent anti-tumour drugs, exceeding the efficacy of conventional antibodies. There is great commercial interest in|developing site-specific payload conjugation technologies. We have established sortaseenzyme|mediated site-specific toxin conjugation to mAbs with sortase A known in the prior art. We aim to develop novel, patentable sortase variants with improved and altered|specificities for extending the technology and IP base of the commercial partner.

Participants

Ulf Grawunder

Wirtschaftspartner

ulf.grawunder@nbe-therapeutics.com

NBE-Therapeutics GmbH Ulf Grawunder Hochbergerstr. 60C 4057 Basel BS CH

Georg Lipps

Kontaktperson

georg.lipps@fhnw.ch

FHNW Fachhochschule Nordwestschweiz Institut für Chemie und Bioanalytik Georg Lipps Gründenstrasse 40 4132 Muttenz BL CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2014-03-02
Date de fin
2018-01-02
Coûts totaux approuvés
CHF 539436.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%